Interestingly, after induction of iron depletion to near-iron deficiency, there was nearly half of the reduction in serum ALT levels in MAFLD patients with T2DM, without descent in non-MAFLD patients with T2DM treated equally (41). The gene discussed is GPT; the disease is Iron deficiency anemia.